Pharmaceuticals, Biotechnology and Life Sciences
A biopharmaceutical company TiGenix focused on allogeneic expanded stem cells, has raised $35.65 million gross proceeds from the sale of 2,300,000 American Depository…
Argenx, a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe…
Biocartis has CE-marked its solid biopsy Idylla NRAS-BRAF Mutation Test. On Thursday, Biocartis said that, together with the CE-marked Idylla…
Karuna Pharmaceuticals and a subsidiary of PureTech Health have finished studying antipsychotic for schizophrenia and Alzheimer’s disease – KarXT. The…
Horizon Discovery Group has provided an update on the commercial operation of its Biomanufacturing business with significant growth in cell…
Johnson&Johnson has decreased its shareholding in Biocartis, the Belgian drugmaker said on Wednesday. In a disclosure of a transparency notification,…
Genticel, a clinical-stage biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus (HPV), has…
GSK has announced on Tuesday that it intends to appoint Deloitte LLP (“Deloitte”) as its auditor with effect from the…
4D Pharma’s Blautix, a single strain live biotherapeutic for the treatment of chronic abdomen disorder, Irritable Bowel Syndrome (IBS), has…
Active Biotech has announced on Tuesday that following the end of the subscription period, the results of Active Biotech’s rights issue…